According to a new report by Polaris Market Research, the global lice treatment market was valued at USD 1.28 billion in 2025 and is projected to reach USD 2.32 billion by 2034, expanding at a CAGR of 6.80% over the forecast period. Growth is underpinned by rising lice infestation awareness, expanding retail and online pharmacy access, and accelerating product approvals for resistance-effective treatments across key end-use settings.

What Is Driving Lice Treatment Market Growth?

Demand is climbing as close-contact transmission in schools and households converges with growing public health awareness campaigns. Manufacturers and healthcare providers are prioritizing early detection and effective treatment, pushing lice treatment adoption across pediatric and school-age populations worldwide. Polaris analysts note that the high prevalence of head lice among children aged 3 to 11 — with the CDC estimating 6 million to 12 million infestations occurring annually in the United States alone — positions the segment for sustained growth through 2034, with retail pharmacies emerging as the largest revenue contributor and prescription medications posting the fastest incremental gains.

Key Trends Shaping the Lice Treatment Industry

Persistent Head Lice Infestations Fuel Recurrent Treatment Demand

Head lice infestations remain prevalent among school-aged children due to close contact, increasing the risk of community transmission and recurrent cases. Growing awareness programs in schools and healthcare settings are promoting early detection and proper treatment, continuously lifting demand for effective, easy-to-use, and safe lice treatment products.

Regulatory Approvals Widen Access to New Treatments

An increasing number of product approvals by regulatory authorities for both prescription and non-prescription lice treatments is expanding the market's regulatory landscape. Governments in several countries are mandating lice control measures across schools, healthcare facilities, and daycare centers, reinforcing structured demand for approved treatment options.

Pediatric Demand and Product Innovation Reshape the Competitive Landscape

Children remain the largest users of lice treatment products, prompting manufacturers to introduce child-friendly, safe formulations that are easy to use. Parental awareness programs and pediatric healthcare recommendations continue to support product adoption, strengthening the market outlook and competitive positioning of key players.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/lice-treatment-market 

Market Segmentation: Breaking Down the Lice Treatment Market

Polaris segments the lice treatment market by type, treatment, distribution channel, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Type

The Pediculosis Capitis segment led the market in 2025, accounting for 76.5% of revenue, on the strength of high head lice prevalence among school children and growing efforts to educate people about early detection. Advances in formulation technology — including new lotions, shampoos, and combing devices — continue to support strong segment growth.

By Treatment

OTC products remain the dominant treatment category, accounting for 61.8% of revenue in 2025, driven by easy accessibility, affordability, and convenient at-home use. Prescription medications are projected to expand at the fastest CAGR of 7.9% through 2034 as demand rises for stronger options addressing resistant or recurring infestations.

By Distribution Channel

Retail pharmacies held a market share of 49.6% in 2025, supported by extensive geographic reach, immediate product availability, and pharmacist guidance. Hospital pharmacies are forecast to grow at the fastest rate, aided by direct access to prescription treatments and healthcare-professional support for complex cases.

Regional Outlook: Where Is the Lice Treatment Market Growing Fastest?

North America led the market in 2025 on the back of a large lice infestation patient pool, strong healthcare expenditure, and widespread treatment availability, accounting for 38.7% of global share. Asia Pacific is expected to post the fastest CAGR of 8.4% through 2034, driven by rising awareness of early detection, growing pharmacy access, and expanding healthcare infrastructure across countries such as India, China, and South Korea.

Competitive Landscape: Leading Lice Treatment Companies

Key players profiled in the report include Bayer AG, Sumitomo Chemical Co. Ltd., Sanofi SA, Pfizer Inc., and Omega Pharma NV, who are focusing on improving product efficacy, formulation innovation, and affordable pricing to strengthen market position across the Pediculosis Capitis and OTC treatment segments outlined above. Recent moves include Pelthos Therapeutics' plan to commercialize XEGLYZE® (abametapir) Lotion for head lice in mid-2027, following its acquisition of the product from Hatchtech in late 2025, deepening the competitive focus on single-application, resistance-effective therapies.

Why It Matters for Buyers Evaluating the Lice Treatment Market

For stakeholders researching the lice treatment market, this report benchmarks market share, segment-level pricing, and forecast data — by type, treatment, distribution channel, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking prescription medications as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Functional Endoscopic Sinus Surgery Market

Whiskey Market

Autonomous Ships Market

Transforming Medication Administration with Subcutaneous Devices

Medical Stick To Skin Adhesives Market

Medical Stick To Skin Adhesives Market

Photovoltaic Materials Market

Specialty Oleochemicals Market

Medical Polymer Market